Filing Flows

Filing Flows › Precigen (PGEN) › Who owns the stock

Who owns Precigen (PGEN) stock

212 funds reported Precigen (PGEN) shares in their latest 13F filings, worth $850M in all. The largest holder is Patient Capital Management, LLC ($109M). Last quarter 110 funds added to their stakes and 68 cut them.

Largest holders of PGEN (13F)Largest holders of PGEN (13F)Patient Capital Management, LLC$109MBlackRock$97.7MState Street$68.4MDiametric Capital, LP$52.8MVanguard Capital Management LLC$45.1MVanguard Group$43.8MTang Capital Management LLC$36.6MBoxer Capital Management, LLC$29.4MGeode Capital Management, LLC$28.6MIridian Asset Management LLC$26.2M

Largest holders (13F)

FundSharesValueChangeQuarter
Patient Capital Management, LLC19,036,976$109Mincrease2026-06-30
BlackRock17,146,921$97.7Mincrease2026-06-30
State Street12,002,465$68.4Mincrease2026-06-30
Diametric Capital, LP9,269,926$52.8Mincrease2026-06-30
Vanguard Capital Management LLC7,906,160$45.1Mincrease2026-06-30
Vanguard Group10,479,452$43.8Mincrease2025-12-31
Tang Capital Management LLC6,417,500$36.6Munchanged2026-06-30
Boxer Capital Management, LLC5,150,000$29.4Mincrease2026-06-30
Geode Capital Management, LLC5,019,028$28.6Mincrease2026-06-30
Iridian Asset Management LLC3,064,571$26.2Mdecrease2026-09-30
Morgan Stanley3,469,628$19.8Mincrease2026-06-30
Occam Crest Management LP3,605,941$19.7Mdecrease2026-06-30
Goldman Sachs Group3,406,456$19.4Mincrease2026-06-30
FMR LLC2,570,183$14.7Mincrease2026-06-30
Vanguard Portfolio Management LLC2,211,172$12.6Mincrease2026-06-30

Precigen's latest quarter

Precigen, Q3 2026: revenue $74.1M (25× year over year), operating margin 52.1%, net earnings $35.8M, operating cash flow $11.9M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most PGEN stock?

By the latest 13F filings: Patient Capital Management, LLC ($109M); BlackRock ($97.7M); State Street ($68.4M); Diametric Capital, LP ($52.8M); Vanguard Capital Management LLC ($45.1M).

What is the short interest in PGEN?

46,390,144 shares were sold short at the 2026-10-15 settlement, -2.43% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.